DMD’s Course With Corticosteroid Use Examined in Review Study

DMD’s Course With Corticosteroid Use Examined in Review Study

296324

DMD’s Course With Corticosteroid Use Examined in Review Study

With current corticosteroid use, people with Duchenne muscular dystrophy (DMD) typically lose their walking ability by their early teens, often need ventilation by their late teens, and usually survive until the third or fourth decade of life, according to a review study into the clinical course of DMD today. The review, “The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review,” was published in the Orphanet Journal of Rare Diseases.…

You must be logged in to read/download the full post.